Comments on: Qwell Pharmaceuticals, Backed by Arch, Raises $7M for New Cancer, Inflammation Drugs http://www.xconomy.com/seattle/2009/01/06/qwell-pharmaceuticals-backed-by-arch-raises-7m-for-new-family-of-cancer-inflammation-drugs/ Business + Technology in the Exponential Economy Sat, 11 Feb 2012 09:14:03 +0000 hourly 1 http://wordpress.org/?v=3.0.4 By: peHUB » Qwell Pharma Raises $7 Million http://www.xconomy.com/seattle/2009/01/06/qwell-pharmaceuticals-backed-by-arch-raises-7m-for-new-family-of-cancer-inflammation-drugs/comment-page-1/#comment-44117 peHUB » Qwell Pharma Raises $7 Million Wed, 07 Jan 2009 14:04:07 +0000 http://www.xconomy.com/?p=7482#comment-44117 [...] Qwell Pharmaceuticals, a Seattle-based drug developer focused on tumors and excess inflammation of skin cells, has raised $7 million in Series A funding, according to Xconomy. Arch Venture Partners and the Wellcome Trust co-led the round. Read more… [...] [...] Qwell Pharmaceuticals, a Seattle-based drug developer focused on tumors and excess inflammation of skin cells, has raised $7 million in Series A funding, according to Xconomy. Arch Venture Partners and the Wellcome Trust co-led the round. Read more… [...]

]]>